SONIC HEDGEHOG MODULATORS
5 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to relates to macrocyclic small molecule inhibitors of the Sonic Hedgehog signaling pathway, syntheses thereof, and intermediates thereto. Such small molecule modulators of the Sonic Hedgehog signaling pathway are useful in the treatment of proliferative diseases (e.g., basal cell carcinoma, Gorlin syndrome, medulloblastoma, or pancreatic cancer), pulmonary diseases (e.g., interstitial pnuemonitis or interstitial pulmonary fibrosis), and developmental disorders (e.g., phocomelia or cyclopia). Novel non-natural macrocycles are provided that inhibit Sonic Hedgehog induced-protein transcription.
-
Citations
84 Claims
- 1. A compound of formula I:
-
3. (canceled)
-
5. (canceled)
-
7. (canceled)
-
13. (canceled)
-
15-30. -30. (canceled)
-
33-38. -38. (canceled)
-
40-42. -42. (canceled)
-
46. (canceled)
-
50. (canceled)
-
54-55. -55. (canceled)
-
57. (canceled)
-
59. (canceled)
-
63. (canceled)
-
65-67. -67. (canceled)
-
69. (canceled)
-
71. (canceled)
-
73. (canceled)
-
75. (canceled)
-
79. A method for the inhibition of Sonic Hedgehog protein-induced transcription in cells, the method comprising contacting a cell with an effective amount of a compound of formula I:
-
80-82. -82. (canceled)
-
83. A method of treating a proliferative disease in a subject suffering therefrom, the method comprising administering to the subject a therapeutically effective amount of a compound of formula I:
-
84-96. -96. (canceled)
Specification